Press Release

RESEARCH TRIANGLE PARK, NC and TORONTO, ON, January 3, 2019 — Analytics 4 Life, a digital health company dedicated to improving existing diagnostic pathways, today announced that it has further strengthened its leadership team with the appointment of William Revelos as Vice President and General Counsel. In his role, Mr. Revelos will be instrumental in helping Analytics 4 Life grow its clinical program and build its patent portfolio. The Company recently announced a research expansion of its CorVista® imaging platform into pulmonary hypertension and that it will be running four clinical studies this year.

“I have had the pleasure of working with Bill for the past ten years,” said Don Crawford, chief executive officer at Analytics 4 Life. “Given his significant patent law expertise and deep understanding of the medical device field, Bill will add valuable perspective as we seek to advance our program. This is an exciting time for Bill and Analytics 4 Life as we continue to expand our operations.”

For nearly ten years, Mr. Revelos has served as principal of Insight Legal Services. In this role, he provided intellectual property counseling and acted as outside in-house counsel to companies in the medical device sector. Prior to Insight Legal Services, Mr. Revelos was General Counsel at Zeltiq Aesthetics (acquired by Allergan), Senior Patent Counsel at Boston Scientific, and General Counsel at TriVascular (acquired by Boston Scientific).

Mr. Revelos holds a B.S.E.M. from the U.S. Air Force Academy, an M.S.M.E. from the University of Dayton, and a J.D. from The George Washington University Law School.

About CorVista® System
CorVista is a non-invasive medical imaging system that is designed to acquire and process patient data and display results in a report accessible via a secure web portal. The system scans signals emitted by the body without radiation, exercise, or pharmacologic stress and wirelessly transmits the signal package to the cloud for processing and report generation. Physicians can interpret and use the results as part of an assessment of their patient. CorVista is an investigational device limited by federal law to investigational use. CorVista is not available for commercial distribution.

About Analytics 4 Life®
Analytics 4 Life is pioneering digital health using artificial intelligence to develop a completely new cardiac diagnostic modality. With an initial focus on coronary artery disease, heart failure, and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac diagnostic platform aimed at improving existing care pathways. Analytics 4 Life is based in Toronto with U.S. headquarters in Washington, D.C.

Contacts

CorVista Health
Chris Bing Ernst
(415) 710-9445
[email protected]

SOURCE: Business Wire